We are looking to add pharma stocks to our portfolio, find multiplex stocks too expensive: Deepak Shenoy

economictimes.indiatimes.com:

Deepak Shenoy, Founder, Capital Mind, says “we thought it would be a washout year for most of pharma. But this quarter seems to be more interesting from the earnings perspective and from a commentary perspective. I do not have much more specifics.

We are looking at stocks here to add to our portfolio. But it is still early, probably only next month before we do something concrete on it. We have not been in pharma for at least a few months now.”It seems to be working out very well for PVR. What's your take? PVR, Inox, the movie multiplex player?Yes, of course.

Honestly, the stock itself has gone all over the place. It is not very different from a price perspective from what it was maybe before the merger and a few years back as well. But in general, they are one of the largest players in the space.

The only thing to worry about is whether any further expansion will trigger any other competition commission kind of moves here. But overall, the exhibition business is starting to do well. There are some short-term and medium-term good things for them in terms of both the Covid opening up story, which has already played out and the fact that movies have made a comeback because movie production had lagged a little bit.

People had gone to OTT for a long time. And now it seems the money is back in movies. We do not know.

They are a good consumption story for India. I am just waiting for the financials to pan out in a better way. They are just a little expensive for me right now.But what about you?I am a lousy guy for movies.

I will wait for them to come to OTT. Right now, I just live too far away from the movies. I actually went once to Mysore to watch Mission Impossible because it was faster to go to Mysore and watch a movie.